Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c

Allarity Therapeutics (NASDAQ: ALLR) reported Q2 EPS of ($0.15).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval